The Nasdaq listed Cosmos Health Inc. has secured a facility worth up to $300 million to support a new treasury strategy based on Ethereum. The firm plans to issue senior secured convertible promissory notes to raise capital for digital asset reserves.
Under the deal, at least 72.5% of funds from each tranche will go directly toward accumulating ETH. The remaining amount will be used for working capital and other business needs. The facility is backed by an institutional investor and managed by Curvature Securities as placement agent.
Cosmos Backs ETH for Long-Term Strategy
This move is part of Cosmos Health’s wider digital transformation, which includes blockchain use cases in areas like supply chain tracking and wellness programmes. The acquired ETH will be custodied and staked through BitGo Trust Company, using secure infrastructure designed for institutional holders.
As noted in the company’s press release, chief executive Grigoris Siokas described the financing as “a strategic milestone for Cosmos Health, offering shareholders direct exposure to ETH, currently one of the most widely adopted digital assets in the world.”
He added that it also supports initiatives such as accelerated product development, advanced R&D innovation, commercial initiatives, and expansion into U.S. manufacturing.
Healthcare Firm’s Entry into Crypto Space
This is a rare step for a healthcare firm, highlighting how more companies are exploring digital assets as part of their financial planning. Similar strategies have been used by the likes of BitMine and SharpLink, currently holding around $3.20B and $2B worth of ETH respectively–as per market data.
While part of the funding will go toward standard operations, Cosmos sees Ethereum as a strategic reserve asset. The financing brings a digital dimension to its treasury while supporting broader company goals.
The fundairing details were filed in a Form 8-K with the U.S. Securities and Exchange Commission (SEC), showing how the capital will be used and the thinking behind the plan. A company spokesperson said the move reflects a long-term focus on growth, not a short-term trial.
Also Read: Indian Govt sends 44K emails for undeclared crypto income
